More than 100.000 products for your scientific research & diagnostic testing

Deals of the Month

What our clients say

  • I must really say, it was a good experience using Sanbio for custom made constructs! I will definitely recommend Sanbio to colleagues.

    Lina Leiss, PhD, University of Bergen, Norway

  • Sanbio is not only a distribution company. Because they develop their own antibodies, you can also contact them for specific technical questions.

    Harry Begthel, Hubrecht Institute Utrecht

  • Top (high) quality histopathology antibodies and leader in neuromuscolar diseases markers.

    Marco D'Erasmo, DBA Italia S.r.l.

  • Sanbio/Monosan is a pleasure to work with as their team provides excellent levels of customer service.

    Rick Bhatt, Newmarket Scientific U.K.

  • Sanbio is always a partner in Diagnostics: troubleshooting and finding quick solutions are the characteristics of the people who work there.

    Karin Kleiverda, LUMC

  • It is easy to approach Sanbio, as they are a pleasant contact and provide good technical support.

    Dr. H.G. Otten, UMC Utrecht

  • Sanbio's knowledge and extensive portfolio helps us to solve many technical related research issues.

    Adrie Atsma, Vitens

Latest news

View all news

Twitter

View all tweets
  • RT @origenebio: How to Make Lentiviral Particles? Join us for a live webinar to learn more. Register now!https://t.co/iIAE2ZGY3X https://t.… October 13, 2017 - Sanbio B.V.
  • RT @SouthernBiotech: Primary antibodies directly bind to a particular antigen of interest. Several of our products allow for direct detecti… October 13, 2017 - Sanbio B.V.
  • RT @ScienCell: Sciencell Human Mammary Fibroblasts (Cat #7630) comes in vials containing >5 x 105 cells in 1 ml volume https://t.co/jFjREj9… October 13, 2017 - Sanbio B.V.

Choose the best Nunc microplates

Nunc Plate guide app for Android™ & Apple™

Affordable, tunable microplate reader

The VersaMax™ from Molecular Devices

We use cookies to ensure that we give you the best experience on our website. More information

Accept